Neuroprotective effect of nitric oxide against NMDA-induced neurotoxicity in the rat retina is associated with tyrosine hydroxylase expression

Brain Research

Volumn 977, Issue 1, 2003, Pages 46-54

  Kitaoka, Yasushi ^a   Kumai, Toshio ^a   Isenoumi, Kazuyuki ^a   Kitaoka, Yuka ^a   Motoki, Masamitsu ^a   Kobayashi, Shinichi ^a   Ueno, Satoki ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopaminergic cell; N Methyl D aspartate; Neuroprotection; Nitric oxide; Retina; Tyrosine hydroxylase mRNA

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; DOPAMINE 1 RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOPAMINE METABOLISM; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MORPHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0038699007     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02696-9     Document Type: Article

References (39)

1. Abreu P., Llorente E., Sanchez J.J., Gonzalez M.C. Nitric oxide inhibits tyrosine hydroxylase of rat median eminence. Life Sci. 67:2000;1941-1946.
2. Alfonso J., Pollevick G.D., Castensson A., Jazin E., Frasch A.C.C. Analysis of gene expression in the rat hippocampus using real time PCR reveals high inter-individual variation in mRNA expression levels. J. Neurosci. Res. 67:2002;225-234.
3. Amano T., Yamakuni T., Okabe N., Kuwahara R., Ozawa F., Hishinuma F. Regulation of nerve growth factor and nerve growth factor receptor production by NMDA in C6 glioma cells. Mol. Brain Res. 14:1992;35-42.
4. Berkowitz B.A., Lukaszew R.A., Mullins C.M., Penn J.S. Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 39:1998;391-396.
5. Canals S., Casarejos M.J., Rodriguez-Martin E., de Bernardo S., Mena M.A. Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures. J. Neurochem. 76:2001;56-68.
6. Cannop B.P., Boegman R.J., Jhamandas K., Beninger R.J. Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis. Brain Res. 676:1995;124-132.
7. Castro N.G., de Mello M.C., de Mello F.G., Aracava Y. Direct inhibition of the N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393. Br. J. Pharmacol. 126:1999;1847-1855.
8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
9. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical culture. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
10. Dkhissi O., Chanut E., Versaux-Botteri C., Minvielle F., Trouvin J.H., Nguyen-Legros J. Changes in retinal dopaminergic cells and dopamine rhythmic metabolism during the development of a glaucoma-like disorder in quails. Invest. Ophthalmol. Vis. Sci. 37:1996;2335-2344.
11. Dkhissi O., Chanut E., Wasowicz M., Savoldelli M., Nguyen-Legros J., Minvielle F., Versaux-Botteri C. Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest. Ophthalmol. Vis. Sci. 40:1999;990-995.
12. Dreyer E.B., Zurakowski D., Schumer R.A., Podos S.M., Lipton S.A. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch. Ophthalmol. 114:1996;299-305.
13. Facci L., Leon A., Skaper S.D. Excitatory amino acid neurotoxicity in cultured retinal neurons: involvement of N-methyl-D-aspartate (NMDA) and non-NMDA receptors and effect of ganglioside GM1. J. Neurosci. Res. 27:1990;202-210.
14. 2+ reduces N-methyl-D-aspartate neurotoxicity in embryonic chick neural retina in vitro. Neurosci. Lett. 57:1985;13-18.
15. Isaacs K.R., de Erausquin G., Strauss K.I., Jacobowitz D.M., Hanbauer I. Differential effects of excitatory amino acids on mesencephalic neurons expressing either calretinin or tyrosine hydroxylase in primary cultures. Mol. Brain Res. 36:1996;114-126.
16. Itzhak Y., Martin J.L., Ail S.F. nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice. NeuroReport. 11:2000;2943-2946.
17. Kashii S., Takahashi M., Mandai M., Shimizu H., Honda Y., Sasa M., Ujihara H., Tamura Y., Yokota T., Akaike A. Protective action of dopamine against glutamate neurotoxicity in the retina. Invest. Ophthalmol. Vis. Sci. 35:1994;685-695.
18. Kashiwagi K., Iizuka Y., Tanaka Y., Mochizuki S., Kajiya F., Araie M., Suzuki Y., Iijima H., Tsukahara S. Dual action of nitric oxide on purely isolated retinal ganglion cells. Curr. Eye Res. 23:2001;233-239.
19. Kerringan-Baumrind L.A., Quigley H.A., Pease M.E., Kerrigan D.F., Mitchell R.S. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest. Ophthalmol. Vis. Sci. 41:2000;741-748.
20. Kim T.W., Kang K.B., Choung H.K., Park K.H., Kim D.M. Elevated glutamate levels in the vitreous body of an in vivo model of optic nerve ischemia. Arch. Ophthalmol. 118:2000;533-536.
21. Kumai T., Tanaka M., Tateishi T., Watanabe M., Nakura H., Asoh M., Kobayashi S. Effects of anti-androgen treatment on the catecholamine synthetic pathway in the adrenal medulla of spontaneously hypertensive rats. Naunyn Schmiedebergs Arch. Pharmacol. 357:1998;620-624.
22. LaVoie M.J., Hastings T.G. Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss. J. Neurochem. 73:1999;2546-2554.
23. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S.V., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
24. Louzada-Junior P., Dias J.J., Santos W.F., Lachat J.J., Bradford H.F., Coutinho-Netto J. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J. Neurochem. 59:1992;358-363.
25. Manzoni O., Prezeau L., Marin P., Deshager S., Bockaert J., Fagni L. Nitric oxide-induced blockade of NMDA receptors. Neuron. 8:1992;653-662.
26. Martin-Martinelli E., Simon A., Vigny A., Nguyen-Legros J. Postnatal development of tyrosine-hydroxylase immunoreactive cells in the rat retina: morphology and distribution. Dev. Neurosci. 11:1989;11-25.
27. Martin-Martinelli E., Savy C., Nguyen-Legros J. Morphometry and distribution of displaced dopaminergic cells in rat retina. Brain Res. Bull. 34:1994;467-482.
28. Mizuno K., Koide T., Yoshimura M., Araie M. Neuroprotective effect and intraocular penetration of nipradiol, αβ-blocker with nitric oxide donative action. Invest. Ophthalmol. Vis. Sci. 42:2001;688-694.
29. Neal M.J., Cunningham J.R., Hutson P.H., Hogg J. Effects of ischaemia on neurotransmitter release from the isolated retina. J. Neurochem. 62:1994;1025-1033.
30. Quigley H.A., Dunkelberger G.R., Green W.R. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am. J. Ophthalmol. 107:1989;453-464.
31. Rauhala P., Lin A.M.Y., Chiueh C.C. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J. 12:1998;165-173.
32. Reif D.W. Delayed production of nitric oxide contributes to NMDA-mediated neuronal damage. NeuroReport. 4:1993;566-568.
33. Rodrigues-Martin E., Casarejos M.J., Bazan E., Canals S., Herranz A.S., Mena M.A. Nitric oxide induces differentiation in the NB69 human catecholamine-rich cell line. Neuropharmacology. 39:2000;2090-2100.
34. Siliprandi R., Canella R., Carmignoto G., Schiavo N., Zanellato A., Zanoni R., Vantini G. N-Methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis. Neurosci. 8:1992;567-573.
35. Tung N.N., Morgan I.G., Ehrlich D. A quantitative analysis of the effects of excitatory neurotoxins on retinal ganglion cells in the chick. Vis. Neurosci. 4:1990;217-223.
36. Vecino E., Ugarte M., Nash M.S., Osborne N.N. NMDA induces BDNF expression in the albino rat retina in vivo. Neuroreport. 6:(10):1999;1103-1106.
37. Vidwans A.S., Kim S., Coffin D.O., Wink D.A., Hewett S.J. Analysis of the neuroprotective effects of various nitric oxide donor compounds in murine mixed cortical cell culture. J. Neurochem. 72:1999;1843-1852.
38. Wu D.K., Cepko C.L. Development of dopaminergic neurons is insensitive to optic nerve section in the neonatal rat retina. Dev. Brain Res. 74:1993;253-260.
39. Yoles E., Schwartz M. Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve. Arch. Ophthalmol. 116:1998;906-910.